Samsung Biologics strike: Union, management resume talks Monday under govt mediation
Synopsis
Key Takeaways
Samsung Biologics, the biotech arm of Samsung Group, has agreed to return to the negotiation table on Monday, 5 May 2025, as a government-mediated effort attempts to resolve the company's first-ever labour strike, now entering its third day. The two sides will renegotiate under the mediation of the Jungbu regional employment and labour office, after an initial round of talks collapsed on Thursday, according to a corporate official.
Background to the Strike
Unionised workers of Samsung Biologics launched the walkout on Friday, marking the first strike in the company's history. Approximately 2,800 of the 4,000 unionised members have participated in the collective action, according to the union. The union has said it plans to continue the strike until Tuesday.
The workers have put forward a set of demands, including a 14 percent increase in both base and performance-related pay, a one-off cash incentive of 30 million won (approximately US$20,389) per worker, and bonuses equivalent to 20 percent of annual operating profit. The company, in contrast, has proposed a combined 6.2 percent increase in base and performance pay.
Why the First Round of Talks Broke Down
The initial arbitration meeting last week ended without progress, reportedly after the labour union demanded that the company replace all of its bargaining committee members as a prerequisite for continuing discussions. The company has characterised this condition as an obstacle to good-faith dialogue.